Learn More
Medchemexpress LLC CDDO-dhTFEA | 1191265-33-4 | 99.64% | 574.72 | 50 MG

Supplier: Medchemexpress LLC HY11267150MG
CDDO-dhTFEA (RTA dh404) is a synthetic oleanane triterpenoid compound that potently activates Nrf2 and inhibits the pro-inflammatory transcription factor NF-κB. It restores hypertension (MAP), increases Nrf2 and the expression of its target genes, attenuates activation of NF-κB and transforming growth factor-β pathways, and reduces glomerulosclerosis, interstitial fibrosis, and inflammation in chronic kidney disease (CKD) rats. For research use only, not for sale to patients.
- Potently activates Nrf2.
- Inhibits the pro-inflammatory transcription factor NF-κB.
- Attenuates activation of NF-κB and transforming growth factor-β pathways.
- Reduces glomerulosclerosis, interstitial fibrosis, and inflammation in chronic kidney disease (CKD) rats.
- Upregulates expression of antioxidant enzymes.
- Protects pancreatic tissue and exhibits anti-inflammatory activity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.